Skip to main content
. Author manuscript; available in PMC: 2024 Jan 27.
Published in final edited form as: Thromb Haemost. 2023 Jan 30;123(5):501–509. doi: 10.1055/s-0043-1761419

Fig. 3.

Fig. 3

Levels of platelet and endothelial activation markers in control mice and tumor-bearing mice. (A) Plasma levels of platelet factor 4 in control mice (n = 11) and tumor-bearing mice (n = 11). (B) Plasma levels of soluble P-selectin in control mice (n = 11) and tumor-bearing mice (n = 11). (C) Plasma levels of soluble VCAM-1 in control mice (n = 11) and tumor-bearing mice (n = 11). (D) Plasma levels of soluble ICAM-1 in control mice (n = 11) and tumor-bearing mice (n = 11). All data are shown as mean ± SD and analyzed by the two-tailed Student’s t-test. *p < 0.05, ****p < 0.0001. SD, standard deviation.